http://www.macleans.ca/topstories/health/article.jsp?content=20051213_117621_117621The end of the period
A new contraceptive will soon let women stop menstruating. Is it the pinnacle of liberation, or a reckless experiment?
LIANNE GEORGE
For the average woman, life holds not two but three certainties: death, taxes and 35 years of monthly hormonal mayhem. Periods can be wretched. But from a young age, girls are comforted with the promise that the bleeding, cramping and radical mood swings are all part of the special alchemy of womanhood. Menstruation is -- to use the mother of all feminine-hygiene euphemisms -- a precious gift. Which is why the introduction of a new product that invites women to opt out of the whole ordeal is something of a cultural upheaval. Health experts are predicting that by this time next year, menstruation will no longer be an inevitable function but rather an optional feature, a bit like power steering or pay-per-view.
In 2006, a new oral contraceptive called Anya, developed to "put women in control of when or if they want to menstruate," is expected to hit the Canadian and U.S. markets. Manufactured by Collegeville, Penn.-based Wyeth Pharmaceuticals -- and currently pending approval by Health Canada -- Anya is the first low-dose birth control pill designed to be taken 365 days a year, without placebos (the hormone-free sugar pills taken at the end of every 28-day cycle). Early findings report that Anya is just as effective in preventing pregnancy as traditional oral contraceptives (98 per cent). And as an added bonus, since Anya provides a steady stream of hormones, it promises to quash a woman's usual cyclical fluctuations, virtually wiping out all the irksome symptoms of PMS.
The elimination of periods -- politely called menstrual suppression -- is an objective the pharmaceutical industry has been chasing for several years. In the fall of 2003, Barr Laboratories of Pomona, N.Y., introduced Seasonale in the U.S., the first extended-cycle contraceptive pill, with the slogan "Fewer periods. More possibilities." Unlike traditional oral contraceptives, which a woman takes for 21 days, followed by seven days of placebo pills, Seasonale is taken for 84 consecutive days, followed by seven days of placebos, which gives her four periods a year instead of the usual 13. Despite widely reported side effects, including irregular bleeding, Seasonale -- still pending approval in Canada -- has quickly emerged as a popular option in the U.S. Last year alone, Barr recorded Seasonale sales of US$87 million. Anya takes this concept and raises it to the next level.
So, for any woman who ever found herself staring down a Tampax vending machine without a quarter, the advent of a drug like Anya would seem an occasion for rejoicing. It will mean all sorts of choices for the next generation of adolescent girls. It will mean being able to customize their cycles to suit their lives. (Maybe she's an athlete who doesn't want to bleed during swim meets. Or maybe she just likes to wear white cotton capris.) It will mean no more tampons, panty liners or maxi pads with wings. No more Midol or hot water bottles. No more feeling not-quite-fresh -- even after a shower.